Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00532909 |
|---|---|
| Brief Title: | Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer |
| First Submitted : | September 20, 2007 |
| First Submitted that Met QC Criteria : | September 20, 2007 |
| First Posted : | September 21, 2007 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 12, 2012 |
| Last Update Posted : | July 16, 2012 (Estimate) |